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Inactivation of selected neurons in vivo can define
their contribution to specific developmental out-
comes, circuit functions, and behaviors. Here, we
show that the optogenetic tool KillerRed selec-
tively, rapidly, and permanently inactivates different
classes of neurons in C. elegans in response to a
single light stimulus, through the generation of reac-
tive oxygen species (ROS). Ablation scales from indi-
vidual neurons in single animals to multiple neurons
in populations and can be applied to freely behaving
animals. Using spatially restricted illumination, we
demonstrate that localized KillerRed activation in
either the cell body or the axon triggers neuronal
degeneration and death of the targeted cell. Finally,
targeting KillerRed to mitochondria results in organ-
elle fragmentation without killing the cell, in contrast
to the cell death observed when KillerRed is targeted
to the plasma membrane. We expect this genetic
tool to have wide-ranging applications in studies of
circuit function and subcellular responses to ROS.
INTRODUCTION
Optogenetic approaches to studying the function of specific
neurons in vivo generally involve the use of light to acutely acti-
vate or inactivate the cells of interest. In particular, inactivation
in Caenorhabditis elegans of specific neurons in vivo can be
used to investigate their contribution to specific network func-
tions and also to study compensation or homeostasis in the re-
maining cells. However, the best-described optogenetic tools
for silencing neurons in C. elegans, halorhodopsin (Zhang
et al., 2007) and archaerhodopsin (Chow et al., 2010; OkazakiCet al., 2012), are light-driven ion pumps (chloride and protons,
respectively) that require constant stimulation to keep neurons
inactive, andmay not be suitable for studying behavior, compen-
sation, or homeostasis over longer timescales.
An alternative way to acutely and permanently inactivate spe-
cific neurons in vivo is to kill them. Investigators have utilized this
approach extensively in C. elegans to define the function of a
wide variety of cells (especially neurons), using a laser micro-
beam to ablate the cells (Avery and Horvitz, 1987, 1989; Fang-
Yen et al., 2012). However, application of the laser-ablation
approach is limited because of the difficulty of ablating multiple
target cells without damaging surrounding cells or tissues, and
the extensive amount of time required to perform surgery on a
large number of animals. Thus, the development of optogenetic
ablation tools that can be spatially and temporally controlled is
highly desirable. An optimal optogenetic ablation tool should
kill cells rapidly, avoid collateral damage to neighboring cells
and tissues, and scale in application from single neurons to
groups of cells in single animals or populations.
KillerRed is a dimeric red fluorescent protein that produces
high levels of reactive oxygen species (ROS) upon illumination
with green light (540–580 nm), thereby inducing cell death (Bulina
et al., 2006). Structurally, KillerRed resembles other GFP-like
proteins, which comprise an 11-strand antiparallel b-barrel that
surrounds a centrally located chromophore (Carpentier et al.,
2009; Pletnev et al., 2009). However, KillerRed is 1,000 times
more toxic than other fluorescent proteins. This higher toxicity
is due to the presence of a long water-filled channel in
KillerRed that allows diffusion ofmolecular oxygen near the chro-
mophore, and is thought to provide a path for electron transfer
during the production of superoxide radicals (Roy et al., 2010;
Serebrovskaya et al., 2009). Similar to the generation of GFP
fluorescence, the phototoxic activity of KillerRed is effective
in vivo and can be induced in mammalian and zebrafish cells
without coexpression of other factors (Bulina et al., 2006; Teh
et al., 2010).ell Reports 5, 553–563, October 31, 2013 ª2013 The Authors 553
Figure 1. KillerRed Activation Disrupts the Function and Morphology of Targeted Neurons and Results in Cell Death
(A) KillerRed activation induces behavioral defects. Animals were illuminated with white light and then scored 24 and 72 hr later for the shrinker phenotype caused
by GABAergic neuron dysfunction. n = 50 for KillerRed and GFP, and 100 for wild-type.
(legend continued on next page)
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Here, we demonstrate that KillerRed can efficiently kill a vari-
ety of neurons in C. elegans, including sensory neurons, inter-
neurons, and motor neurons. We show that the effect of
KillerRed is cell-autonomous and does not spread to nearby
neurons. Our results indicate that KillerRed disruption of
neuronal function is rapid and can be used to alter the circuits
and behavior of freely moving animals. In addition, the tool is
highlymodifiable, with ablation efficiency dependent upon illumi-
nation duration and intensity. We also demonstrate that certain
neurons are resistant to KillerRed damage, raising the intriguing
possibility that some cells possess increased intrinsic protection
mechanisms against ROS. We further show that subcellular
localization of KillerRed dramatically alters its function, with
mitochondria localization resulting in specific disruption of
organelle morphology. Finally, using selective illumination, we
show that exposure of individual neuronal compartments, such
as the cell body or the axon, is sufficient to induce neuronal
damage and death.
RESULTS
Expressing KillerRed in C. elegans GABA Neurons
Results in Light-Dependent Cell Death
We established the consequences of KillerRed activation in
different sets of C. elegans neurons, including motor neurons,
mechanosensory neurons, chemosensory neurons, and inter-
neurons (details of the KillerRed constructs and illumination
parameters can be found in Table S1 available online). We first
generated transgenic animals expressing cytosolic KillerRed
under the control of the GABAergic neuron-specific promoter
Punc-47, which drives expression in 26 motor neurons required
for coordinated movement (McIntire et al., 1997). Cytosolic
KillerRed activation in GABAergic neurons caused a ‘‘shrinker’’
phenotype (i.e., longitudinal shortening of the body upon head
touch) in the animals 24 hr after illumination, consistent with
loss of GABAergic neuronal function (Figure 1A; McIntire et al.,
1993). Furthermore, neuronal function remained disrupted
72 hr after KillerRed activation (Figure 1A), suggesting that the
affected neurons were dead rather than merely damaged. To
examine themorphology of KillerRed-expressing neurons before
and after KillerRed activation, we coexpressed GFP in the
targeted cells (Figure 1B). Twenty-four hours after KillerRed acti-
vation, we found that the morphology of the GABAergic neurons(B and B0) Confocal images of the GABAergic nervous system of GABA::KillerRe
(C) Nomarski image of affected GABAergic neuron cell bodies 24 hr after KillerR
(D and D0) CEPs before (D) and 24 hr after (D0) illumination. After illumination, the d
are smaller and rounded.
(E and E0) RIA interneuron before (E) and 24 hr after (E0) illumination, with the cel
(F and F0) Cholinergic nervous system before (F) and 24 hr after (F0) illumination.
smaller cell bodies.
(G–H’) Fluorescent images of axonal and neuronal damage in ALM and PLM bef
completely cleared (G0) and the PLM axon has disappeared (H’).
(I) Nomarski image of ablated ALM cell body 24 hr after illumination.
(J) Quantification of cell death 24 hr after illumination. n = 155 cells (CEP and AD
(K) Light touch response 24 hr after illumination in wild-type and KillerRed-expres
light touch in both the head and tail of the animal. n = 50 animals.
(L) Quantification of cell death in touch neurons 24 hr after illumination. n = 107 ce
neuron cell bodies, arrows mark processes, and arrowheads mark dorsal and ve
See also Table S1.
Cwas severely disrupted, with axonal processes that were frag-
mented and broken, often with large blebs, or missing altogether
(Figure 1B0). The cell bodies of the affected neurons were round
and swollen, and appeared smaller than those in nonilluminated
animals, consistent with neuronal death. To confirm that the
morphological changes observed based on GFP fluorescence
reflected cell death, we analyzed the GABAergic neurons by
differential interference contrast (DIC) microscopy and found
that the cell bodies of affected neurons displayed swelling, the
presence of vacuole-like structures, and nuclear changes (Fig-
ure 1C), all of which are phenotypes consistent with cell death.
The observed structural and behavioral defects were specific
and dependent on KillerRed expression and activation. Illumina-
tion of either wild-type animals or animals expressing only GFP in
GABAergic neurons did not elicit a shrinker phenotype (Fig-
ure 1A). Moreover, expression and illumination of the spectrally
similar fluorophore mCherry did not cause a detectable behav-
ioral defect (data not shown). Furthermore, prior to illumination,
neurons expressing KillerRed displayed no morphological or
functional deficits, indicating that neuronal deathwas dependent
upon KillerRed activation (Figures 1A and 1B). Thus, KillerRed
activation in GABAergic neurons permanently disrupts function
and results in cell death.
KillerRed Can Be Used to Efficiently Ablate Multiple
Classes of Neurons
Our experiments demonstrated that KillerRed can disrupt
neuronal function. Next, we asked whether we could improve
the efficiency of disruption. KillerRed is dimeric (Bulina et al.,
2006; Carpentier et al., 2009; Pletnev et al., 2009), and we
reasoned that increased efficiency might result from expression
as a tandem dimer, as previously reported for other multimeric
fluorescent proteins (Campbell et al., 2002; Shaner et al.,
2004). We generated a tandem-dimer version of KillerRed
(tdKillerRed) and found that it was significantly more effective
than monomeric KillerRed at disrupting GABA neuron function.
After illumination with green light (5.1 mW/mm2 for 5 min),
100% of tdKillerRed animals (n = 11) exhibited a shrinker pheno-
type, compared with only 14% for monomeric KillerRed (n = 14;
p < 0.0001). We also localized tdKillerRed to the plasma mem-
brane using a myristoylation tag (myr-tdKillerRed). Membrane-
targeted dimeric KillerRed had efficiency similar to that of
soluble dimeric KillerRed (92% shrinker, n = 13, p = 1.0). Wed (Punc-47::KillerRed) animals before (B) and 24 hr after (B0) illumination.
ed activation.
endrites of CEP neurons (arrows) are fragmented and the cell bodies (asterisks)
l body and axon degenerated in (E’).
Activation results in fragmentation of neuronal processes as well as fewer and
ore (G and H) and 24 hr after (G’ and H’) illumination. After illumination, ALM is
E), 48 cells (RIA), 74 cells (AWB), and 17 cells (AFD).
sing animals. After KillerRed activation, there is a reduction in the response to
lls (AVM and PVM) and 214 cells (ALM and PLM). In all figures, asterisks mark
ntral nerve cords. Error bars indicate 95% confidence intervals.
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Figure 2. KillerRed Activation Results in Immediate Disruption of
Neuronal Function
(A) Illumination of animals expressing KillerRed in cholinergic neurons results in
immediate and permanent disruption of movement. n = 50 for unilluminated,
n = 20 for immediate (just after the end of illumination) and 6 hr time points, and
n = 41 for 16 hr time point. Error bars indicate 95% confidence intervals.
(B) A freely swimming L1 larva before KillerRed activation in GABAergic motor
neurons (top panel). The same larva immediately following 5 min exposure to
green light illumination (40 mW/mm2) displays uncoordinated locomotion
(bottom panel).
See also Table S1.used myr-tdKillerRed for some of the subsequent experiments
(Table S1).
To determine whether other neurons could be targeted by
KillerRed, we generated different transgenic strains expressing
KillerRed in the dopaminergic neurons CEP, ADE, and PDE
(Pdat-1::myr-tdKillerRed); the interneuron RIA (Pglr-3::myr-
tdKillerRed); the cholinergic neurons (approximately 120
neurons; Punc-17::myr-tdKillerRed); the amphid sensory neu-
rons AWB (Pstr-1::myr-tdKillerRed) and AFD (Pgcy-8::myr-
tdKillerRed); and the mechanosensory neurons ALM (L/R),
PLM(L/R), AVM, and PVM (Pmec-4::KillerRed). Like the
GABAergic motor neurons, the dopaminergic neurons CEP
and ADE and the interneuron RIA were efficiently killed after
KillerRed activation (Figures 1D, 1E, and 1J). The cholinergic
neurons were also efficiently killed, although the maximum effi-
ciency could not be determined because the animals died (Fig-
ure 1F). This lethal phenotype is consistent with a requirement
for cholinergic neuron function for survival of animals in early
developmental stages (Alfonso et al., 1993). In comparison
with these cell types, the AWB and AFD amphid neurons were
killed with lower efficiency (Figure 1J). The dopaminergic PDE
neurons were also killed with lower efficiency (26 out of 60 cells),
even though the other dopaminergic neurons were efficiently
killed in the same animals. We also tested the efficiency of
KillerRed in the mechanosensory neurons, which mediate a spe-
cific behavior: response to light touch. We found that expression
and activation of KillerRed in the mechanosensory neurons
caused deficits in mechanosensation (Figure 1K). Consistent
with this loss of touch sensitivity, KillerRed activation also
caused efficient neuronal cell death in ALM and PLM neurons
(Figures 1G–1I and 1L). However, the AVM and PVM neurons
were refractory to axonal degeneration or cell death. Thus,
KillerRed can ablate many neuronal types in C. elegans, and is
effective at targeting single neurons as well as entire neuronal556 Cell Reports 5, 553–563, October 31, 2013 ª2013 The Authorsclasses, with selected neurons being specifically resistant to
disruption.
KillerRed Induces Immediate Inactivation of Illuminated
Neurons
Although the morphological effects of KillerRed activation in
neuronal cell bodies and processes are not apparent immedi-
ately after activation, it is possible that KillerRed disrupts
neuronal function more rapidly than it affects neuronal
morphology. To test this, we used two strategies. First, we
took advantage of the profound consequence of KillerRed acti-
vation in cholinergic neurons, which triggers paralysis in a coiled
posture, similar to what is observed in animals that lack cholin-
ergic neurotransmission (Rand, 1989). To determine the time
necessary for neuronal function to be disrupted byKillerRed acti-
vation, we quantified this uncoordinated behavior at various
times after illumination. This revealed that functional disruption
was both immediate and permanent (Figure 2A). Immediately
after completion of the 5 min illumination period, the animals
exhibited a robust, uncoordinated phenotype consistent with
loss of cholinergic neuron function. This functional deficit per-
sisted long after activation, suggesting that disruption was not
due to temporary inactivation, but rather to permanent disruption
of neuronal function followed by cell death.
Second, we used an optogenetic illumination system that
allowed us to expose single, freely swimming animals to intense
green laser light while monitoring their behavior before, during,
and after illumination (Leifer et al., 2011). When we used this sys-
tem to analyze the effect of KillerRed activation in GABAergic
motor neurons of freely swimming L1 larvae, we found that acti-
vation of KillerRed caused a severe deficit in locomotion, which
was observed immediately after the end of the illumination
period (Figure 2B; Movies S1 and S2). Together, these experi-
ments demonstrate that KillerRed activation can rapidly and
permanently disrupt neuronal function. In addition, our inactiva-
tion experiments in the GABAergic neurons of L1 animals sug-
gest that these neurons make a greater contribution to normal
locomotion of L1 animals than was previously appreciated.
KillerRed-Dependent Neuronal Death Is Caspase
Independent and Can Be Improved by Mutating
ROS-Detoxifying Enzymes
KillerRed is thought to act as a type II photosensitizer, producing
superoxide anion radicals rather than singlet oxygen (Pletnev
et al., 2009; Shu et al., 2011). Superoxide is scavenged by super-
oxide dismutases (SODs), which catalyze the conversion of
superoxide radicals to hydrogen peroxide and thus limit cellular
damage.C. elegans has a total of five SODs, two of which (sod-1
and sod-5) are cytoplasmic Cu/Zn SODs (the remaining three
SODs are mitochondrial Fe/Mn SODs [sod-2 and sod-3] and
an extracellular Cu/Zn SOD [sod-4]) (Landis and Tower, 2005).
We found that a sod-1 mutant background, which eliminates
one of the cytoplasmic SODs, increased the efficiency of abla-
tion in AWB, a neuron that normally is refractory to KillerRed
damage (Figure 3A). These data support a model in which
KillerRed exerts its effect via superoxide, and demonstrate that
the effect of KillerRed in normally resistant cells can be enhanced
by specific genetic mutations.
Figure 3. KillerRed Phototoxicity Is Enhanced in SOD Mutants and Does Not Require the Caspase CED-3
(A) Myr-tdKillerRed activation ablates AWB amphid neurons more effectively in sod-1(tm776) mutant animals. n = 74 cells (wild-type) and 38 cells (sod-1).
(B) Neuronal cell death induced byMyr-tdKillerRed activation in cholinergic neurons does not require ced-3(n717). The illumination protocol was adjusted to avoid
killing the animals (see Table S1). n = 132 cells (wild-type) and 79 cells (ced-3).
(C) Neuronal cell death induced by cytosolic KillerRed activation in mechanosensory neurons does not require ced-3(n717). For ced-3, n = 95 cells (AVM, PVM)
and 190 cells (ALM, PLM); for wild-type, n = 107 cells (AVM and PVM) and 214 cells (ALM and PLM; same data as Figure 1L). Phenotypes were determined 24 hr
after illumination. In all panels, error bars indicate 95% confidence intervals.
See also Table S1 and Movies S1 and S2.In C. elegans, apoptotic cell death requires the caspase CED-
3, whereas necrotic cell death does not (Ellis and Horvitz, 1986;
Hall et al., 1997). We tested whether KillerRed-mediated
neuronal cell death occurred through apoptosis by examining
the requirement for ced-3. Cell death, as well as the other
morphological and behavioral consequences of KillerRed activa-
tion, was as robust in ced-3mutants as in the wild-type for both
acetylcholinemotor neurons andmechanosensory neurons (Fig-
ures 3B and 3C). Further, the pathology of neuronal cell death
induced by KillerRed included cell swelling, vacuolation, and
nuclear changes (Figures 1C and 1I), which is similar to previous
observations of necrosis-like neuronal cell death (Hall et al.,
1997) but in contrast to the compact morphology of apoptotic
cells. These observations suggest that KillerRed does not act
via an apoptotic pathway and may instead kill neurons through
a necrotic, caspase-independent mechanism.
KillerRed’s Effects Are Cell Autonomous and Do Not
Spread to Adjacent Neurons
To test the cell autonomy of KillerRed’s cytotoxicity, we exam-
ined the morphology of neurons located adjacent to KillerRed-
targeted cells in three different experiments. First, we examined
AWA and AWB, which are sensory neurons located in the head.
The cell bodies of the AWA and AWB neurons are located next to
each other within the lateral ganglia; their axons project into the
nerve ring and their dendrites fasciculate with each other (White
et al., 1986). We found that activation of KillerRed in the AWB
neuron resulted in its structural disruption after illumination, butChad no effect on the structure of AWA (Figures 4A and 4B).
Second, we examined cholinergic and GABAergic motor neu-
rons. These neurons are synaptic partners; their cell bodies are
located near the ventral nerve cord and their processes fascicu-
late together in the dorsal and ventral nerve cords (White et al.,
1986). We found that KillerRed activation in the GABAergic neu-
rons did not affect the morphology of the cholinergic neurons
(Figures 4C and 4D). Furthermore, KillerRed activation in
GABAergic neurons caused a GABAergic-specific functional
defect (Figure 1A) rather than the coiled-paralysis defect caused
by activation in cholinergic neurons (Figures 1F and 2). Similar
specificity was observedwhenGABA neuronswere imaged after
KillerRed activation in the cholinergic neurons, that is, activation
in cholinergic neurons did not affect the GABA neurons. Finally,
we tested whether KillerRed activation in the PLMmechanosen-
sory neuron had any effect on the morphology of the nearby PLN
neuron. Both PLM and PLN neurons have their cell bodies in the
lumbar ganglia, and their processes run adjacent to each other
for the entire posterior half of an animal’s body (White et al.,
1986). Activation of KillerRed in PLM had no effect on the axon
or cell body of PLN (Figures 4E–4G). Together, these results
indicate that KillerRed-mediated functional disruption and cell
damage is cell-autonomous and does not spread beyond the
targeted cell (or cells).
Selective Illumination Results in Neuronal Cell Death
We next investigated the effect of selective illumination on
different regions of the animal’s body or on defined regions ofell Reports 5, 553–563, October 31, 2013 ª2013 The Authors 557
Figure 4. KillerRed Phototoxicity Does Not
Spread to Neighboring Neurons
(A) AWA neuron intact after illumination (green,
Podr-10::GFP).
(B) AWB degenerated neuron in the same animal
as in (A) (red, Pstr-1::myr-tdKillerRed).
(C) Cholinergic neurons after illumination (green,
Punc-17::GFP).
(D) Affected GABAergic neurons after illumination
in the same animal as in (C) (red, Punc-47::myr-
tdKillerRed).
(E) PLN neuron after illumination (red, Plad-
2::mCherry).
(F) PLM neurons expressing KillerRed after illumi-
nation in the same animal as in (E) (green, Pmec-
4::GFP). In all panels, asterisks mark cell bodies,
arrows mark processes, and arrowheads mark
dorsal (top) and ventral (bottom) nerve cords.
(G) Quantification of cell death in PLM and PLN
neurons in animals expressing KillerRed in PLM
only. Animals were scored for PLN death only if
PLM had died; thus, PLM death is 100%. n = 25
animals in which both PLM and PLN were scored.
In all panels, phenotypes were determined 24 hr
after illumination.
See also Table S1.individual neurons. For these experiments, we chose themecha-
nosensory neurons ALM and PLM and used a spatially restricted
illumination scheme similar to that used previously for optoge-
netic stimulation and inhibition of neurons (Stirman et al.,
2011). Specifically, we first imaged animals for GFP to locate
the neurons expressing KillerRed without inducing cell damage.
Then, using an LCD projector controlled by a LabVIEW program,
we illuminated selected regions (such as the anterior half or pos-
terior half of the animal’s body, or the cell body or axon of a single
neuron; Figure 5). Using high-magnification lenses with a small
focal depth (e.g., 1003), we were able to confine illumination
with precision and reproducibility. Targeting the anterior or pos-
terior half of the animal induced cell death of specific neurons
included in the respective illuminated regions (Figures 5A–5C).
As was the case with the nontargeted illumination, AVM and
PVM were resistant to KillerRed-induced damage. When
activation was confined to a limited portion of a single neuron,
we found that targeting only the cell body of the ALM
mechanosensory neuron resulted in cell damage and death (Fig-
ures 5D and 5E). Similarly, when the illumination was directed
selectively to the axon, we observed robust cell death (>40%
of cases), with the remaining animals presenting axonal
degeneration in regions beyond the irradiated sections. Thus,
even though expression of KillerRed was not spatially limited,558 Cell Reports 5, 553–563, October 31, 2013 ª2013 The Authorsregional illumination was enough to
produce KillerRed-mediated cell damage
and death.
Mitochondrial Targeting Results in
Organelle-Specific Effects
The experiments described above show
that both membrane-targeted and cyto-plasmic KillerRed can disrupt neuronal function and kill neurons.
To test whether KillerRed function is dependent on subcellular
localization, we targeted tandem dimeric KillerRed to mitochon-
dria using the tom-20 targeting sequence, which results in local-
ization of KillerRed to the outer surface of the mitochondrion
(Ichishita et al., 2008; Kanaji et al., 2000). We performed these
experiments in body wall muscles because the mitochondria in
these cells have a well-defined morphology, which enabled us
to assess the effect of KillerRed on cell structure and function
and on the mitochondria themselves. We found that KillerRed
was efficiently targeted to mitochondria, and that mitochondria
labeled with KillerRed (without activation) had normal mor-
phology consisting of a reticulated network (Figure 6A).
Further, animals that expressedmitochondria-targeted KillerRed
(mt-tdKillerRed) in all of their body wall muscles displayed
normal movement in the absence of light activation, demon-
strating that muscle function was not disrupted by mt-
tdKillerRed expression (data not shown). By contrast, when
mt-tdKillerRed-expressing animals were exposed to green light,
we observed an immediate and dramatic change in mitochon-
dria morphology in muscle. mt-tdKillerRed activation disrupted
the reticulated network of mitochondria and resulted in small,
spherical mitochondria of various sizes (Figure 6B). Surprisingly,
we did not observe behavioral deficits in these animals,
Figure 5. Selected Region Illumination Can
Be Used in Combination with KillerRed to
Induce Cell-Specific Killing
(A and C) Illumination of the anterior half body of
the animal causes selective ablation of ALM
neurons, whereas PLM neurons are intact. n = 25
animals.
(B and C) Illumination of the posterior half of the
animal’s body ablated PLM neurons, leaving intact
ALMs. n = 24 animals.
(D and E) Selective illumination of either the soma
or axon of ALM neurons can cause damage and
neuronal ablation. n = 25 animals for soma and 19
animals for axon illumination. In all of the images,
the green arrowhead points to the targeted neuron
or axon before illumination, asterisks indicate the
same cell 24 hr after illumination, and white
arrowheads point to different neuronal cell bodies
in the animal.
See also Table S1.suggesting that activation of mt-tdKillerRed did not kill muscle
cells (Figure 6G). By contrast, expression of plasma mem-
brane-targeted KillerRed (myr-tdKillerRed) in the same muscle
cells resulted in cell death and immediate behavioral deficits
after activation (Figures 6E and 6F). Since mt-tdKillerRed did
not kill muscles, we performed studies to test whether mito-
chondrial morphology could recover after KillerRed-mediated
disruption.We found that by 48 hr after disruption, themitochon-
dria had recovered normal morphology (Figures 6C and 6D).
Together, these results demonstrate that subcellular targeting
of KillerRed enables the generation of local and specific cell-
biological phenotypes.
Use of KillerRed with Other Optical Tools
A number of optical tools are currently being used in C. elegans,
including the optogenetic tool channelrhodopsin (Nagel et al.,
2005) and the reactive oxygen generator miniSOG (Qi et al.,
2012). Because KillerRed is excited by green light, whereas these
other tools are excited by blue light, we considered that it might
be possible to address them separately in a single animal byCell Reports 5, 553–563,using different illumination wavelengths.
To determine the feasibility of this idea,
we compared the requirements for acti-
vation of KillerRed, channelrhodopsin,
and miniSOG in the cholinergic motor
neurons. The activity of all three tools
has been described in these cells (Figures
1F and 2; Liu et al., 2009; Qi et al., 2012;
Zhang et al., 2007). First, we determined
the feasibility of using KillerRed in
combination with miniSOG.We irradiated
animals expressing miniSOG in cholin-
ergic motor neurons (CZ14527) using
0.57 mW/mm2 of blue light for 30 min as
previously described (Qi et al., 2012;
Table S1). This treatment affected 100%
of the animals: 42% were paralyzed andthe remaining animals could move but were sluggish. Similarly,
we irradiated animals expressing KillerRed in cholinergic
neurons with the same intensity (0.57 mW/mm2) and time of
green light, and again observed 100% affected animals, with
76% paralysis and 24% sluggish movement (Figure 7A). Next,
we swapped the illumination conditions, that is, we illuminated
miniSOG animals with 0.57 mW/mm2 of green light and
KillerRed animals with 0.57 mW/mm2 of blue. This treatment
had little to no effect, although approximately 6% of the
KillerRed animals did react to blue light illumination (Figure 7A).
Finally, we asked whether higher-intensity activation could be
used for miniSOG. We had previously observed that C. elegans
can tolerate green light at 46mW/mm2 for 15minwith no adverse
effects (other than KillerRed activation; Figure 1). However,
exposing wild-type worms (n = 20) to blue light at 8 mW/mm2
for 10 min resulted in 100% lethality, consistent with previous
results (Edwards et al., 2008). Together, these data suggest
that KillerRed andminiSOG can be separately addressed in vivo.
Next, we determined the feasibility of using KillerRed in
conjunction with channelrhodopsin. Again, we focused on theOctober 31, 2013 ª2013 The Authors 559
Figure 6. KillerRed Activation at Mito-
chondria Results in Organelle Damage but
Cell Survival
(A–D) Mitochondria in body wall muscles express
mt-tdKillerRed and were imaged before (A) or at
various times after (B–D) illumination.
(E and F) Body wall muscles express plasma
membrane KillerRed and were imaged before (E)
and 16 hr after (F) illumination. GABA neurons
express GFP.
(G) Average thrash rate in liquid of animals
expressing mitochondria KillerRed in muscles
before and after illumination, corresponding to (A)
and (B). n = 9 for before illumination and 10 for after
illumination; error bars indicate SEM.
(H) Phenotype distribution of animals expressing
plasma membrane KillerRed in muscles after
illumination, corresponding to (F). n = 41; error
bars indicate 95% confidence intervals.
See also Table S1.cholinergic motor neurons, which are a well-described site for
channelrhodopsin activation (Liu et al., 2009; Zhang et al.,
2007). We tested whether activation of channelrhodopsin could
be performed independently of KillerRed activation. We acti-
vated channelrhodopsin in cholinergic motor neurons using
0.47 mW/mm2 of blue light, which caused 100% of the animals
to stop moving (n = 23). By contrast, 2.2 mW/mm2 of green light
had no effect on these animals (n = 22). As we previously deter-
mined that an even lower intensity of green light could be used to
activate KillerRed, and a higher intensity of blue light could
be used without activating KillerRed (Figure 7A), these experi-
ments indicate that KillerRed can be used in multimodal
experiments with channelrhodopsin. Finally, we confirmed
these experiments in mechanosensory neurons. As in the cholin-
ergic neurons, we found that prolonged illumination of KillerRed
strains at the appropriate wavelength and intensity to activate
channelrhodopsin had very little effect, although axon damage
was observed in a small percentage of animals (Figures 7B
and 7C). These data confirm that KillerRed can be used in con-
junction with channelrhodopsin in C. elegans, as well as in
conjunction with other fluorescent tools that are excited by
blue or cyan light.
DISCUSSION
KillerRed is a new tool in the C. elegans optogenetic toolkit that
can kill and inactivate cells in populations of animals with
extremely high temporal and spatial control. The effect of
KillerRed is immediate and cell-autonomous, with no spreading
of killing, or even damage, to surrounding cells or tissues. This
critical property makes KillerRed a powerful biological tool that560 Cell Reports 5, 553–563, October 31, 2013 ª2013 The Authorscan be applied in a wide variety of cell-
perturbation studies in vivo, at scales
ranging from single to multiple cells in
both single animals and populations. For
example, the rapidity and efficacy of this
genetically encoded cell-ablation reagent
will now allow investigators to examinethe acute effects of disrupting specific neurons during behavioral
performance. KillerRed can also be used for longer behavioral
studies, since ablated neurons never recover function. For
example, our data indicate that GABA neurons have an essential
function in the locomotion of L1 larvae. Similarly, our data indi-
cate that ablation of acetylcholine neurons in L4 stage animals
results in relatively rapid lethality (within 24 hr of ablation), sug-
gesting that C. elegans has an acute requirement for cholinergic
neurotransmission for viability. One potential concern for such
behavioral studies is the fact that because KillerRed damages
and kills neurons, rather thanmerely silencing them, it is possible
that secondary effects on the remaining cells in the network
might complicate analysis. However, our data demonstrate
that, at least for the neurons assessed here, the effects of
ablation are restricted to the cells that express KillerRed.
Further, because KillerRed is excited by green light, it can be
used in combination with other optogenetic tools that are excited
by blue light, such as GFP, GCaMP, channelrhodopsin, and
miniSOG. The green light activation of KillerRed may have
some additional practical advantages in C. elegans, as worms
tolerate high levels of green light, but actively avoid—and can
be killed by—equivalent amounts of blue light (Edwards et al.,
2008). The selective-illumination method we describe here may
also have additional applications, such as ablating a neuron
from a distance by targeting a region of its axon (this is particu-
larly important when using KillerRed expressed in cells whose
cell bodies are in very close proximity and therefore are more
difficult to target individually), and investigating ROS effects in
axonal sections.
Our results also indicate that subcellular localization of
KillerRed can be exploited to study specific cell-biological
Figure 7. KillerRed Can Be Used in Multimodal Optical Experiments
(A) Comparison of the effects of KillerRed and miniSOG in acetylcholine
neurons illuminated with either blue or green light. n = 33 for miniSOG/blue,
n = 21 for miniSOG/green, n = 32 for KillerRed/blue, and n = 21 for KillerRed/
green. Error bars show 95% confidence interval for the paralyzed phenotype.
Phenotypes were determined 10 min after illumination.
(B and C) Effect of KillerRed in mechanosensory neurons illuminated with
either blue (b) or cyan (c) light. n = 102 for blue light and n = 64 for cyan light.
Phenotypes were determined 24 hr after illumination.
See also Table S1.functions. Targeting and activating KillerRed at the plasmamem-
brane is sufficient to inactivate and kill cells. This rapid and lethal
effect could be due to the susceptibility of membrane lipids to
oxidation. For example, unsaturated lipids are highly susceptible
to oxidative stress, resulting in the generation of toxic com-
pounds such as hydroxynonenal and acrolein (Catala´, 2010;
Fatokun et al., 2008). In addition to causing loss of membrane
fluidity and destruction of the plasma membrane barrier, these
toxic compounds react with membrane proteins, resulting in
inactivation of critical proteins such as the neuronal glucose
transporter, the glutamate transporter, and Na+/K+ ATPases
(Barnham et al., 2004; Keller et al., 1997; Mark et al., 1995; SmithCet al., 2009). In contrast, targeting and activating KillerRed at
mitochondria results in the specific disruption (and eventual re-
covery) of organelle morphology, without killing cells. A potential
explanation for the local effect of KillerRed on mitochondria is
that ROS are quenched rapidly and thus the effective diffusion
rate is very low. Alternatively, it is possible that the TOM20 tag
affects KillerRed function, allowing for mitochondrial damage
but preventing cell killing. Interestingly, another optogenetic
reactive oxygen generator, miniSOG, requires mitochondrial
targeting to kill neurons (Qi et al., 2012). miniSOG generates
mainly singlet oxygen, whereas KillerRed generates mainly
superoxide (Pletnev et al., 2009; Shu et al., 2011; this work).
These data suggest that different ROS may affect mitochondria
and cell function in different ways. KillerRed thus enables the
dissection of local effects of ROS.
ROS are toxic cellular molecules that need to be kept in check
for a neuron to function over a long period of time, and ROS
accumulation correlates with a variety of neurodegenerative dis-
eases (DiMauro and Schon, 2008; Uttara et al., 2009). Therefore,
defining the nature of the cytotoxicity of KillerRed, a generator of
ROS, offers a significant opportunity to genetically investigate
the mechanisms that regulate cellular responses to ROS. Our
findings show that selective neurons, such as AVM, PVM, and
AWB, are resistant to damage caused by KillerRed activation
and ROS. KillerRed expression is weaker in PVM than in other
neurons, so the reduced killing effect could be due to the pres-
ence of fewer molecules in the cell. However, AVM and AWB
express KillerRed at levels comparable to those observed in
other neurons, suggesting that they might have a higher intrinsic
capacity to buffer ROS. One such mechanism could be a higher
expression of molecules, such as SOD-1, that are able to catab-
olize ROS into nontoxic elements. Our data demonstrating that a
mutation in SOD-1 is able to increase the cytotoxic effect of
KillerRed activation in AWB provide support for this idea,
although additional mechanisms might also be in place. We
expect that the application of KillerRed shown here will provide
greater flexibility and control for genetic studies of both neuronal
function and ROS-induced neuronal damage in vivo.EXPERIMENTAL PROCEDURES
Strains and Molecular Biology
Nematodes were cultured using standard methods. All experiments were
performed at 22C except when otherwise noted. A C. elegans version of
the KillerRed coding sequence was synthesized (GenScript) using worm-
optimized codons and synthetic introns (Fire et al., 1990; Stenico et al.,
1994). Flanking regions for Multisite Gateway (Invitrogen) were included and
the KillerRed construct was placed in pDONR221. tdKillerRed was generated
from this monomeric construct using the same linker sequences as tdTomato
(Serebrovskaya et al., 2009; Shaner et al., 2004). tdKillerRed was targeted to
the plasma membrane through the addition of a myristoylation tag to generate
myr-tdKillerRed (Gitai et al., 2003). Promoters were cloned into the [4-1] slot of
Multisite Gateway. Final expression constructs were generated with LR
clonase into the destination vector pCFJ150 (Frøkjaer-Jensen et al., 2010).
For experiments with the mechanosensory neurons, we used the following
transgenes and mutations: zdIs5(Pmec-4::GFP), vdEx405[Pmec-4::KillerRed
(20 ng/ml) + odr-1::DsRED (30 ng/ml)], LGIV ced-3(n717), and vdEx167[Plad-
2::mCherry (25 ng/ml) + Podr-1::dsRED (30 ng/ml)]; Neumann et al., 2011).
Standard molecular-biology methods were used. The Pmec-4::KR construct
was generated by cloning a KillerRed cDNA (Evrogen) into a pSM vectorell Reports 5, 553–563, October 31, 2013 ª2013 The Authors 561
(a derivative of pPD49.26 [Fire et al., 1990], a kind gift from Steve McCarroll
and Cori Bargmann) containing Pmec-4. KillerRed was amplified with primers
containing BamHI restrictions sites and inserted into pSM Pmec-4 digested
with the same enzyme.
DNA constructs were injected into the germline using standard methods
(Mello et al., 1991). Expression of KillerRed in the correct cells was verified
by fluorescence microscopy.
KillerRed Activation and Imaging
Light from a 200 W mercury bulb (PhotoFluor II; 89 North) was filtered with a
562/20 nm filter. The resulting green light was trained into a 5 mm liquid-light
guide. The output from the liquid-light guidewas directed through a collimating
lens (LA1951-A; Thorlabs) and a focusing lens (LA1027-A). Light intensity was
measured with a power meter (PM100A; Thorlabs). Illuminations were done in
upside-down PCR tube caps in 30 ml of M9 medium on ice to minimize sample
heating. L4 stage transgenic worms were used in all experiments. The animals
were allowed to crawl on unseeded plates prior to the experiment to remove
excess bacteria. Different neuronal cell types required different illumination
protocols to result in optimal killing. Illumination times, light intensities, and
transgenic lines carrying myr-tdKillerRed are shown in Table S1. An UltraVIEW
VoX (PerkinElmer) spinning disc mounted on a Nikon Ti-E Eclipse inverted
microscope and a 603CFI Plan Apo, NA 1.0 oil objective were used to capture
z stacks of nonilluminated and illuminated neurons. Cellular damage in illumi-
nated neurons was documented 18–24 hr after illumination.
Illumination ofmechanosensory neuronswasperformedon animals immobi-
lized onNGMagar plates with tetramisole hydrochloride (0.03%), using a Leica
MZ10F fluorescence dissecting microscope with an EtDsRed filter (green light
530–560 nm) and 803 magnification (intensity 3.8 mW/mm2). Twenty-four
hours after irradiation, the animals were mounted on 4% agar pads and visual-
ized byepifluorescenceusing aZeissAxioimagerZ1andaZeissAxioimagerA1
microscope. A CoolSNAP HQ2 camera (Photometrics) was used for imaging.
Metamorph software was used to analyze the collected images.
Selective illumination was performed using the LCD projector system as
previously described (Stirman et al., 2011). GFP fluorescence was used to
image the cells and define the location of the soma and axon. A green filter
(543–593 nm) was used to activate KR in regions of interest selected after
imaging. Typical power densities were 2–3 mW/mm2. In all experiments
performed using this system, the illumination time was 1 hr. The length of
the axonal processes that were selectively illuminated was 80 mm in all cases.
Extensive degeneration was defined as damage that extended beyond 10%of
the illuminated length along the axon.
Acute KillerRed activation using freely swimmingwormswas performed on a
modified version of the COLBERT system (Leifer et al., 2011). Briefly, a freely
moving L1 larva was imaged with a 203 microscope objective on an inverted
Nikon microscope (TE2000). The fluorescence video was taken with a
CoolSNAP CCD camera (Photometrics). A digital micromirror device was
used to reflect green laser light to illuminate targeted regions of the worm,
inducing KillerRed activation in GABAergic motor neurons.
Activation of miniSOG was performed using the same Photofluor II system
employed forKillerRed,butwithafilter at theappropriatewavelength (TableS1).
Statistics
Statistical comparisons were made using the two-tailed Fisher’s exact test
(http://www.graphpad.com/quickcalcs/contingency1/), and 95% confi-
dence intervals were calculated using http://www.graphpad.com/quickcalcs/
confInterval1/.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one table and two movies and can be
foundwith this article online at http://dx.doi.org/10.1016/j.celrep.2013.09.023.
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